4
Changes in Ownership
ALX ONCOLOGY HOLDINGS INC Filed Acc 0001415889-24-011128
PRESIDENT & CSO sold 50,000 shares at $14.20 ($710,195)
- PRESIDENT & CSO acquired 25,846 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pons Jaume PRESIDENT & CSO | 2024-04-16 | Option exercise 10b5-1 | +25,846 | $0.99 | $25,588 | 654,205 | D: show line 1 in the form |
| Pons Jaume PRESIDENT & CSO | 2024-04-16 | Sale 10b5-1 | −50,000 | $14.20 | $710,195 | 604,205 | D: show line 2 in the form |
| Open-market sales · 50,000 sh · avg $14.20 · $710,195 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pons Jaume PRESIDENT & CSO | 2024-04-16 | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −25,846 | 204,433 | D: show line 3 in the form |
Loading xslF345X05/form4-04182024_080417.xml…